Literature DB >> 26066921

Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration.

Corey S Davis1, Derek Carr1, Jessica K Southwell1, Leo Beletsky1.   

Abstract

Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades. Law enforcement officers (LEOs) are often the first emergency responders to arrive at an overdose, but they are not typically equipped with naloxone. This is rapidly changing; more than 220 law enforcement agencies in 24 states now carry naloxone. However, rollout in some departments has been hampered by concerns regarding officer and agency liability. We systematically examined the legal risk associated with LEO naloxone administration. LEOs can be authorized to administer naloxone through a variety of mechanisms, and liability risks related to naloxone administration are similar to or lower than those of other activities in which LEOs commonly engage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26066921      PMCID: PMC4504282          DOI: 10.2105/AJPH.2015.302638

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  46 in total

1.  Time course of changes in breathing pattern in morphine- and oxycodone-induced respiratory depression.

Authors:  K Leino; L Mildh; K Lertola; T Seppälä; O Kirvelä
Journal:  Anaesthesia       Date:  1999-09       Impact factor: 6.955

2.  Physicians' perceptions of the risk of being sued.

Authors:  A G Lawthers; A R Localio; N M Laird; S Lipsitz; L Hebert; T A Brennan
Journal:  J Health Polit Policy Law       Date:  1992       Impact factor: 2.265

3.  Physicians' fears of malpractice lawsuits are not assuaged by tort reforms.

Authors:  Emily R Carrier; James D Reschovsky; Michelle M Mello; Ralph C Mayrell; David Katz
Journal:  Health Aff (Millwood)       Date:  2010-09       Impact factor: 6.301

4.  Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA.

Authors:  Corey S Davis; Scott Burris; Julie Kraut-Becher; Kevin G Lynch; David Metzger
Journal:  Am J Public Health       Date:  2005-02       Impact factor: 9.308

5.  Drug poisoning deaths in the United States, 1980-2008.

Authors:  Margaret Warner; Li Hui Chen; Diane M Makuc; Robert N Anderson; Arialdi M Miniño
Journal:  NCHS Data Brief       Date:  2011-12

6.  Intranasal administration of naloxone by paramedics.

Authors:  Erik D Barton; Joseph Ramos; Christopher Colwell; Jeff Benson; Jeff Baily; William Dunn
Journal:  Prehosp Emerg Care       Date:  2002 Jan-Mar       Impact factor: 3.077

7.  Prevention of fatal opioid overdose.

Authors:  Leo Beletsky; Josiah D Rich; Alexander Y Walley
Journal:  JAMA       Date:  2012-11-14       Impact factor: 56.272

Review 8.  A systematic review of community opioid overdose prevention and naloxone distribution programs.

Authors:  Angela K Clark; Christine M Wilder; Erin L Winstanley
Journal:  J Addict Med       Date:  2014 May-Jun       Impact factor: 3.702

9.  Community-based opioid overdose prevention programs providing naloxone - United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-02-17       Impact factor: 17.586

10.  Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.

Authors:  Robin A Pollini; Caleb J Banta-Green; Jazmine Cuevas-Mota; Mitcheal Metzner; Eyasu Teshale; Richard S Garfein
Journal:  Subst Abuse Rehabil       Date:  2011-10
View more
  20 in total

1.  Implementation of online opioid overdose prevention, recognition and response trainings for professional first responders: Year 1 survey results.

Authors:  Janie Simmons; Sonali Rajan; Lloyd Goldsamt; Luther Elliott
Journal:  Drug Alcohol Depend       Date:  2016-10-11       Impact factor: 4.492

2.  U.S. Re-Licensure Opioid/Pain Management Continuing Education Requirements in Dentistry, Dental Hygiene, and Medicine.

Authors:  R Constance Wiener; Christopher Waters; Ruchi Bhandari; Alcinda K Trickett Shockey; Fotinos Panagakos
Journal:  J Dent Educ       Date:  2019-06-10       Impact factor: 2.264

3.  A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Eur J Epidemiol       Date:  2017-12-12       Impact factor: 8.082

4.  Co-prescribing naloxone does not increase liability risk.

Authors:  Corey S Davis; Scott Burris; Leo Beletsky; Ingrid Binswanger
Journal:  Subst Abus       Date:  2016 Oct-Dec       Impact factor: 3.716

5.  Naloxone perspectives from people who use opioids: Findings from an ethnographic study in three states.

Authors:  Miriam Boeri; Aukje K Lamonica
Journal:  J Am Assoc Nurse Pract       Date:  2020-04-01       Impact factor: 1.165

6.  Making Naloxone Rescue Part of Basic Life Support Training for Medical Students.

Authors:  Helen E Jack; Katherine E Warren; Sivakumar Sundaram; Galina Gheihman; John Weems; Ali S Raja; Emily S Miller
Journal:  AEM Educ Train       Date:  2018-03-30

7.  Assessing Spatial Relationships between Prescription Drugs, Race, and Overdose in New York State from 2013 to 2015.

Authors:  Phillip L Marotta; Tim Hunt; Louisa Gilbert; Elwin Wu; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  J Psychoactive Drugs       Date:  2019-05-05

8.  Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.

Authors:  Sarah Cercone Heavey; Alan M Delmerico; Gale Burstein; Cheryll Moore; William F Wieczorek; R Lorraine Collins; Yu-Ping Chang; Gregory G Homish
Journal:  J Community Health       Date:  2018-04

Review 9.  Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.

Authors:  Rosanna Smart; Bryce Pardo; Corey S Davis
Journal:  Addiction       Date:  2020-07-08       Impact factor: 6.526

Review 10.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.